Mandy Juárez

440 total citations
8 papers, 344 citations indexed

About

Mandy Juárez is a scholar working on Infectious Diseases, Molecular Biology and Cancer Research. According to data from OpenAlex, Mandy Juárez has authored 8 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Molecular Biology and 3 papers in Cancer Research. Recurrent topics in Mandy Juárez's work include Parasitic Diseases Research and Treatment (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Mandy Juárez is often cited by papers focused on Parasitic Diseases Research and Treatment (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Mandy Juárez collaborates with scholars based in Mexico, Australia and Austria. Mandy Juárez's co-authors include Alejandro Schcolnik‐Cabrera, Alfonso Dueñas‐González, Bernardo Oldak, Mayra Cruz‐Rivera, Ana Flisser, Fela Mendlovic, Alma Chávez‐Blanco, Guadalupe Domínguez-Gómez, José Díaz‐Chávez and Fernanda I. Saldívar‐González and has published in prestigious journals such as Scientific Reports, Life Sciences and APOPTOSIS.

In The Last Decade

Mandy Juárez

8 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mandy Juárez Mexico 7 113 104 66 65 58 8 344
Yanquan Xu China 12 127 1.1× 27 0.3× 101 1.5× 37 0.6× 74 1.3× 28 347
Blanca E. Callejas Mexico 9 111 1.0× 41 0.4× 97 1.5× 64 1.0× 107 1.8× 15 330
Luhui Shen United States 10 180 1.6× 43 0.4× 55 0.8× 51 0.8× 88 1.5× 23 384
Ai-Ling Tian China 14 113 1.0× 31 0.3× 117 1.8× 52 0.8× 53 0.9× 24 370
Darine W. El-Naccache United States 10 107 0.9× 31 0.3× 34 0.5× 76 1.2× 124 2.1× 13 350
Minkyoung Cho South Korea 11 128 1.1× 58 0.6× 34 0.5× 24 0.4× 138 2.4× 25 363
Emma Murphy United Kingdom 10 65 0.6× 39 0.4× 54 0.8× 49 0.8× 189 3.3× 14 429
Jonadab E. Olguín Mexico 14 75 0.7× 26 0.3× 104 1.6× 100 1.5× 175 3.0× 27 355
Alberto Yairh Limón-Flores Mexico 10 65 0.6× 93 0.9× 35 0.5× 28 0.4× 247 4.3× 25 550

Countries citing papers authored by Mandy Juárez

Since Specialization
Citations

This map shows the geographic impact of Mandy Juárez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mandy Juárez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mandy Juárez more than expected).

Fields of papers citing papers by Mandy Juárez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mandy Juárez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mandy Juárez. The network helps show where Mandy Juárez may publish in the future.

Co-authorship network of co-authors of Mandy Juárez

This figure shows the co-authorship network connecting the top 25 collaborators of Mandy Juárez. A scholar is included among the top collaborators of Mandy Juárez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mandy Juárez. Mandy Juárez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Vargas‐Castillo, Ariana, Mandy Juárez, Lilia G. Noriega, et al.. (2025). Metabolic reprogramming and synergistic cytotoxicity of genistein and chemotherapy in human breast cancer cells. Life Sciences. 370. 123562–123562. 4 indexed citations
2.
Schcolnik‐Cabrera, Alejandro, Alma Chávez‐Blanco, Guadalupe Domínguez-Gómez, et al.. (2021). Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy. Scientific Reports. 11(1). 5222–5222. 16 indexed citations
3.
Juárez, Mandy, Alejandro Schcolnik‐Cabrera, Guadalupe Domínguez-Gómez, et al.. (2020). Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug. Cancer Chemotherapy and Pharmacology. 85(6). 1153–1163. 29 indexed citations
4.
Schcolnik‐Cabrera, Alejandro, Mandy Juárez, Bernardo Oldak, et al.. (2020). In Vitro Employment of Recombinant Taenia solium Calreticulin as a Novel Strategy Against Breast and Ovarian Cancer Stem-like Cells. Archives of Medical Research. 51(1). 65–75. 12 indexed citations
5.
Schcolnik‐Cabrera, Alejandro, Alma Chávez‐Blanco, Guadalupe Domínguez-Gómez, et al.. (2020). The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells. Oncology Letters. 20(3). 3053–3060. 11 indexed citations
6.
Schcolnik‐Cabrera, Alejandro, Bernardo Oldak, Mandy Juárez, et al.. (2019). Calreticulin in phagocytosis and cancer: opposite roles in immune response outcomes. APOPTOSIS. 24(3-4). 245–255. 81 indexed citations
7.
Juárez, Mandy, Alejandro Schcolnik‐Cabrera, & Alfonso Dueñas‐González. (2018). The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug.. PubMed. 8(2). 317–331. 143 indexed citations
8.
Domínguez-Gómez, Guadalupe, Alma Chávez‐Blanco, José L. Medina‐Franco, et al.. (2017). Ivermectin as an inhibitor of cancer stem‑like cells. Molecular Medicine Reports. 17(2). 3397–3403. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026